Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release

Aripiprazole in schizophrenia and schizoaffective disorder: A review

(2010) Emmanuel Stip et al.   CLINICAL THERAPEUTICS

Assessing brain free fraction in early drug discovery

(2010) Kevin D Read et al.   Expert Opinion on Drug Metabolism & Toxicology

Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders

(2009) Keming Gao et al.   Expert Review of Neurotherapeutics

Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis

(2009) Nuria Cruz et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study

(2008) Gerhard Gründer et al.   AMERICAN JOURNAL OF PSYCHIATRY

Metabolism of Quetiapine by CYP3A4 and CYP3A5 in Presence or Absence of Cytochrome B5

(2008) G. V. Bakken et al.   DRUG METABOLISM AND DISPOSITION

Prolactin and dopamine: What is the connection? A Review Article

(2008) Peter Fitzgerald et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Antipsychotic-Induced Hyperprolactinemia

(2008) Jolene R Bostwick et al.   PHARMACOTHERAPY

The Psychopharmacology Algorithm Project at the Harvard South Shore Program: An Update on Psychotic Depression

(2008) Hesham M. Hamoda et al.   HARVARD REVIEW OF PSYCHIATRY